Olanzapine | Interleukin Related interleukin-related.com

Product Name :
Olanzapine

Search keywords :
Dopamine Receptor D1

drugId :
null

Target Vo:
Dopamine D1 receptor

Target Vo Short Name :
DRD1

Moa_Name:
Dopamine D1 receptor antagonists

First Approval Country :
EU

First Approval Date Filter:
1996

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Alkermes Inc

Active Indication_Name:
Depressive Disorder, Major

In Active Indication_Name:
Opioid-Related Disorders

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
V5-tag Mouse mAb Description
IKK beta Rabbit mAb medchemexpress
SPI1 Antibody (YA118): SPI1 Antibody (YA118) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PU.1. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts